Can software reduce unnecessary spending in healthcare industry?

Cara Livernois | | Health Exec | Economics

Technology can improve organization of patient files, create limbs with 3D printers and connect patients and doctors around the world. Jon Markman, president of Markman Capital Insight, thinks that technology just might be able to cure healthcare.

Markman analyzes how large healthcare companies, such as Kaiser Permanente and Anthem, have utilized the power of technology to save money and keep patients healthy. For example, Kaiser Permanente’s HealthConnect software has mastered data exchange and maintaining digital records for all of its facilities, saving the company $1 billion.

“As the process unfolds, cost savings for industry and lower prices for consumers is likely. It will also create many new businesses and give investors many new opportunities,” wrote Markman. “That’s a good reason to be optimistic.”

Read the full story by clicking the link below:

Technology Ready To Cure Healthcare

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Related Content

Merck spends up to $2B to license new weight loss drug with potential heart benefits
Insulet wins $452M in lawsuit against rivals over medical device trade secrets
Medical device company cuts 70% of staff in push to meet Medtronic obligations
Cleerly’s momentum continues as AI specialists raise $106M
Operations manager, doctors charged in $70M imaging kickback scheme
Private-equity watchdog warns against nominating Marc Rowan as Treasury Secretary

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.